The LAMA2-RD Conference Hosted by Istanbul Nişantaşı University’s Faculty of Medicine Successfully Concluded at Maslak NeoTech Campus on March 27–29, 2026, with Strong Participation
The LAMA2-RD Conference on 27–29 March 2026 brought together experts, patient associations, and families from 17 countries to share scientific developments, clinical approaches, and training on the rare muscle disorder.
The LAMA2-RD (laminin alpha-2-related dystrophy) Conference, hosted by Istanbul Nişantaşı University’s Faculty of Medicine, successfully concluded at Maslak NeoTech Campus on March 27–29, 2026, with strong participation.
Organized under the leadership of Prof. Dr. Haluk Topaloğlu, the conference brought together clinicians, researchers, patient associations and families from 17 countries. The three-day event comprehensively addressed the clinical features, treatment processes and current scientific developments concerning LAMA2-RD, a rare and progressive muscle disease.
Experts highlighted recent advances in neuromuscular diseases, emphasizing that developments in SMA treatment offer hope for similar diseases.
The conference also included a training program for pediatric neurologists titled “Neuromuscular Diseases for Young Enthusiasts.”
Implemented through cooperation between the LAMA2-RD network, Maastricht University and Istanbul Nişantaşı University, the event made important contributions to supporting scientific research, increasing academic knowledge exchange and bringing international experts onto a common platform.
Extending beyond academia to include awareness activities for patients and families, this strong collaboration laid the groundwork for developing multidisciplinary approaches and sustainable solutions for rare diseases.
